Novartis - D/G to HOLD - Cosentyx Drives 5% 2026 EBIT Hit (TP CHF 110, 14pgs)

For access to the full note, please contact Naresh Chouhan ( )

Novartis AG: 1 director

A director at Novartis AG sold 2,600 shares at 97.158CHF and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board mem...

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 09/04/2025

Short term view - GBP-CHF : The major resistance is close.

The trend remains neutral. Prices will have to break above the peak at CHF 1.3104 for the trend to be positive again with an invalidation level below CHF 1.2740.Arguments :- The major resistance is close.- The moving average is capping prices.

Analyse court terme - GBP-CHF : La résistance majeure est proche.

La tendance est toujours neutre. Il faut franchir le sommet à 1,3104 CHF pour que la tendance devienne positive avec une invalidation sous 1,2740 CHF.Arguments :- La résistance majeure est proche.- La moyenne mobile sert de résistance.

Short term view - GBP-USD : Pull-back

The trend is momentarily interrupted by a consolidation on a shorter time horizon but prices remain below the invalidation level at $1.3210. It can resume at anytime towards the target at $1.2600.Arguments :- Prices are pulling back to the major resistance level (previously a support). The fall will resume afterwards.- The falling moving average confirms our opinion.